BDBM423220 4-methyl-6-(4- (((3S,5R)-3-methyl- 5-(4-methyl-1-oxo- 1,3- dihydroisobenzofur- an-5-yl)piperazin- 1-yl)methyl)-1H- imidazol-1- yl)nicotinonitrile::US10501449, Example 98-I

SMILES C[C@H]1CN(Cc2cn(cn2)-c2cc(C)c(cn2)C#N)C[C@H](N1)c1ccc2C(=O)OCc2c1C

InChI Key InChIKey=VOSSLQPSWSECLU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 423220   

TargetATP-sensitive inward rectifier potassium channel 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423220(US10501449, Example 98-I | 4-methyl-6-(4- (((3S,5R...)
Affinity DataIC50: 23nMAssay Description:The coverslip plated with cells was placed in the experiment chamber perfused with bath solution composed of (in mM): 135 NaCl, 5 KCl, 2 CaCl2, 1 MgC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2020
Entry Details
US Patent